Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
san francisco blog main
4
×
amgen
biotech
boston blog main
boston top stories
new york blog main
new york top stories
pfizer
san diego blog main
san diego top stories
san francisco top stories
startups
abbvie
adverum biotechnologies
alzheimer's disease
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
detroit top stories
diagnostics
gilead sciences
indiana blog main
indiana top stories
merck
national
novartis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
What
ceo
4
×
drug
4
×
acquisitions
biggest
bio
roundup
week
year
aces
albert
announced
athena
big
biotech
bourla
build
buy
cancer
chief
cholesterol
company
company’s
countouriotis
crispr
daniel
debut
dyne’s
financing
flexible
future
gets
gilead
imports
inclisiran
key
lowering
maker
maps
meant
measured
Language
unset
unknown
Current search:
drug
×
ceo
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push